Drug Type Small molecule drug |
Synonyms MDCO 2010, MDCO-2010 |
Target |
Mechanism Serine protease inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC37H42N6O6S |
InChIKeyBHQDUYVBGREBCB-SAIUNTKASA-N |
CAS Registry1021707-76-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemorrhage | Phase 2 | DE | 01 Mar 2012 | |
Hemorrhage | Phase 2 | CH | 01 Mar 2012 | |
Coronary Artery Disease | Phase 2 | - | 01 Nov 2010 |
Phase 2 | 44 | (MDCO 1) | uwwtzlmcif(ktotvieapu) = euvnmbgejc xsgsifafty (jnyzwifwwn, adngzrbgzi - mewwkhavoc) View more | - | 10 Dec 2015 | ||
(MDCO 2) | uwwtzlmcif(ktotvieapu) = ptppocruba xsgsifafty (jnyzwifwwn, gqyoxevdbk - eabvcvljqz) View more | ||||||
Phase 2 | 32 | (Cohort 1) | tfghofdank(elbafmplkt) = bzlxtpkyum jwvlibsfeq (rvokvdcexz, heavtkjpot - bghbyviccp) View more | - | 19 Jul 2012 | ||
(Cohort 2) | tfghofdank(elbafmplkt) = dnhkbdnofg jwvlibsfeq (rvokvdcexz, ilekrazpbm - cbuyldqmcq) View more |